BRPI0520568A2 - uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv - Google Patents
uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpvInfo
- Publication number
- BRPI0520568A2 BRPI0520568A2 BRPI0520568-9A BRPI0520568A BRPI0520568A2 BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2 BR PI0520568 A BRPI0520568 A BR PI0520568A BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- wall skeleton
- cell wall
- hpv infection
- nocardia rubra
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510105533.7 | 2005-09-23 | ||
CN2005101055337A CN1935262B (zh) | 2005-09-23 | 2005-09-23 | 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途 |
PCT/CN2005/001977 WO2007033533A1 (fr) | 2005-09-23 | 2005-11-23 | Utilisation du squelette de paroi cellulaire de nocardia rubra en vue de produire des médicaments favorisant la résistance au virus du papillome humain (vph) |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0520568A2 true BRPI0520568A2 (pt) | 2009-05-19 |
BRPI0520568B1 BRPI0520568B1 (pt) | 2019-10-08 |
BRPI0520568B8 BRPI0520568B8 (pt) | 2021-05-25 |
Family
ID=37888528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0520568A BRPI0520568B8 (pt) | 2005-09-23 | 2005-11-23 | uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv |
Country Status (9)
Country | Link |
---|---|
US (1) | US8460722B2 (pt) |
EP (1) | EP1938826B1 (pt) |
JP (1) | JP4854742B2 (pt) |
KR (1) | KR20080048542A (pt) |
CN (1) | CN1935262B (pt) |
BR (1) | BRPI0520568B8 (pt) |
HK (1) | HK1100533A1 (pt) |
RU (1) | RU2394586C2 (pt) |
WO (1) | WO2007033533A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526119A (zh) * | 2010-12-23 | 2012-07-04 | 辽宁纳可佳生物制药有限公司 | 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法 |
CN116898881A (zh) * | 2017-01-11 | 2023-10-20 | 福建省山河药业有限公司 | 红色诺卡氏菌细胞壁骨架在制备治疗痤疮的药物/护肤品中的用途及其药物/护肤品组合物 |
CN111727235B (zh) * | 2019-01-15 | 2024-03-15 | 辽宁天安生物制药股份有限公司 | 赤红球菌产品及其制药用途 |
CN112040962A (zh) * | 2019-03-14 | 2020-12-04 | 辽宁格瑞仕特生物制药有限公司 | 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途 |
US20220193148A1 (en) | 2019-04-24 | 2022-06-23 | Liaoning Greatest Bio-Pharmaceutical Co. Ltd. | Use of nocardia rubra cell wall skeleton in treatment of thermal injury |
US20230071748A1 (en) | 2020-01-21 | 2023-03-09 | Liaoning Greatest Bio-Pharmaceutical Co., Ltd. | Use of nocardia rubra cell wall skeleton in regenerative medicine |
CN115025128A (zh) * | 2022-06-24 | 2022-09-09 | 辽宁格瑞仕特生物制药有限公司 | 红色诺卡氏菌细胞壁骨架在治疗宫颈病变中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5393792A (en) * | 1991-11-20 | 1995-02-28 | Advance Biofactures Of Curacao, N.V. | High dosage topical forms of collagenase |
CN1094288A (zh) * | 1993-04-23 | 1994-11-02 | 福建省微生物研究所 | 利用红色诺卡氏菌制造细胞壁骨架粉末的方法 |
JP4859341B2 (ja) | 2001-07-19 | 2012-01-25 | 昭 林 | ヒト免疫療法 |
CN1291725C (zh) * | 2002-03-08 | 2006-12-27 | 沈阳胜宝康生物制药有限公司 | 用于治疗宫颈糜烂的红色诺卡氏菌细胞壁骨架制剂及其制法 |
AR041171A1 (es) | 2002-09-06 | 2005-05-04 | Univ London | Modulador inmune |
AU2003261624A1 (en) | 2003-09-05 | 2005-03-29 | Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. | A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion |
CN1879661B (zh) | 2005-06-16 | 2012-06-20 | 辽宁纳可佳生物制药有限公司 | 红色诺卡氏菌细胞壁骨架在制备抗真菌感染的药物中的用途 |
CN101073583A (zh) | 2006-05-19 | 2007-11-21 | 沈阳胜宝康生物制药有限公司 | 红色诺卡氏菌细胞壁骨架在制备药物中的用途 |
-
2005
- 2005-09-23 CN CN2005101055337A patent/CN1935262B/zh active Active
- 2005-11-23 KR KR1020087009291A patent/KR20080048542A/ko not_active Application Discontinuation
- 2005-11-23 US US12/067,891 patent/US8460722B2/en active Active
- 2005-11-23 RU RU2008109165/15A patent/RU2394586C2/ru active
- 2005-11-23 BR BRPI0520568A patent/BRPI0520568B8/pt active IP Right Grant
- 2005-11-23 WO PCT/CN2005/001977 patent/WO2007033533A1/zh active Application Filing
- 2005-11-23 EP EP05811912.4A patent/EP1938826B1/en active Active
- 2005-11-23 JP JP2008531506A patent/JP4854742B2/ja active Active
-
2007
- 2007-08-08 HK HK07108619.7A patent/HK1100533A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2008109165A (ru) | 2009-10-27 |
US8460722B2 (en) | 2013-06-11 |
EP1938826B1 (en) | 2014-11-12 |
RU2394586C2 (ru) | 2010-07-20 |
BRPI0520568B1 (pt) | 2019-10-08 |
CN1935262A (zh) | 2007-03-28 |
CN1935262B (zh) | 2010-12-29 |
JP2009508883A (ja) | 2009-03-05 |
EP1938826A1 (en) | 2008-07-02 |
EP1938826A4 (en) | 2011-09-07 |
JP4854742B2 (ja) | 2012-01-18 |
BRPI0520568B8 (pt) | 2021-05-25 |
US20090028973A1 (en) | 2009-01-29 |
WO2007033533A1 (fr) | 2007-03-29 |
KR20080048542A (ko) | 2008-06-02 |
HK1100533A1 (en) | 2007-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0520568A2 (pt) | uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv | |
AR106702A2 (es) | Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento | |
BRPI0408347B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
HN2006009000A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
MX2010004576A (es) | Derivados de pirimidina novedosos. | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
ECSP099044A (es) | Compuestos de pirimido fusionados | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
DOP2011000176A (es) | Compuestos organicos | |
CL2006001266A1 (es) | Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas. | |
ATE386534T1 (de) | Orale darreichungsform enthaltend probiotische bakterien | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
BRPI0716495A2 (pt) | (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos. | |
CL2004000930A1 (es) | Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos. | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
HN2001000281A (es) | Nuevas imidazotriazinonas sustituidas | |
ATE485261T1 (de) | Salicylsäurederivate | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
EP2816035A3 (en) | Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction | |
ECSP11010811A (es) | Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio | |
MX2021015846A (es) | Derivados de antraciclina. | |
WO2008073863A3 (en) | Preparation and utility of substituted allylamines | |
WO2007083190A3 (en) | Water insoluble helichrysum extract, process for preparing the same and uses thereof | |
MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. (CN) ; LIAONING NAKEJIA BIOPHARMACEUTICAL CO., LTD. (CN) Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. |
|
B25G | Requested change of headquarter approved |
Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. |
|
B25D | Requested change of name of applicant approved |
Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B25K | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Owner name: LIAONING GREATEST BIO-PHARMACEUTICAL CO., LTD. (CN Free format text: RETIFICADO O DESPACHO 25.4 PUBLICADO NA RPI 2508 DE 29/01/2019 SOB O ITEM (71). |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |